000 02374 a2200601 4500
005 20250513235324.0
264 0 _c20010719
008 200107s 0 0 eng d
022 _a0022-1767
024 7 _a10.4049/jimmunol.166.9.5782
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiyauchi-Hashimoto, H
245 0 0 _aCarcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cMay 2001
300 _a5782-91 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a9,10-Dimethyl-1,2-benzanthracene
_xantagonists & inhibitors
650 0 4 _aAdjuvants, Immunologic
_xantagonists & inhibitors
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aApyrase
_xbiosynthesis
650 0 4 _aCarcinogens
_xantagonists & inhibitors
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDermatitis, Contact
_xgenetics
650 0 4 _aDinitrofluorobenzene
_xadministration & dosage
650 0 4 _aDinoprostone
_xbiosynthesis
650 0 4 _aDisease Models, Animal
650 0 4 _aEar
_xpathology
650 0 4 _aEdema
_xchemically induced
650 0 4 _aFemale
650 0 4 _aImmunosuppressive Agents
_xantagonists & inhibitors
650 0 4 _aIndomethacin
_xadministration & dosage
650 0 4 _aInflammation
_xchemically induced
650 0 4 _aInterleukin-10
_xbiosynthesis
650 0 4 _aLangerhans Cells
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Hairless
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Inbred CBA
650 0 4 _aMice, Knockout
650 0 4 _aSkin
_ximmunology
650 0 4 _aTumor Necrosis Factor-alpha
_xbiosynthesis
650 0 4 _aUp-Regulation
_xgenetics
650 0 4 _aXeroderma Pigmentosum
_xgenetics
650 0 4 _aXeroderma Pigmentosum Group A Protein
700 1 _aKuwamoto, K
700 1 _aUrade, Y
700 1 _aTanaka, K
700 1 _aHorio, T
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 166
_gno. 9
_gp. 5782-91
856 4 0 _uhttps://doi.org/10.4049/jimmunol.166.9.5782
_zAvailable from publisher's website
999 _c11247859
_d11247859